Singapore's Cordlife Group launches umbilical cord tissue banking in Philippines

The Philippine subsidiary of Singapore-listed Cordlife Group, a leading cord blood and tissue banking service provider, has launched a new umbilical cord tissue banking service. -- FILE PHOTO: CORDLIFE
The Philippine subsidiary of Singapore-listed Cordlife Group, a leading cord blood and tissue banking service provider, has launched a new umbilical cord tissue banking service. -- FILE PHOTO: CORDLIFE

The Philippine subsidiary of Singapore-listed Cordlife Group, a leading cord blood and tissue banking service provider, has launched a new umbilical cord tissue banking service.

This will allow expectant parents to store their newborn's umbilical cord, and the stem cells it contains, for potential use in future therapeutic applications, the company said in a statement on Monday.

The umbilical cord is abundant with two types of stem cell, epithelial stem cells and mesenchymal stem cells, which hold immense potential in repairing injured tissues and organs as well as treating various diseases, according to Dr Arvin Faundo, medical director of Cordlife Philippines.

"The introduction of umbilical cord tissue banking in Philippines represents the latest milestone for Cordlife, one which reflects our dedication to introducing pioneering products and services to our customers, said Mr Jeremy Yee, Cordlife's executive director and chief executive officer.

"We take great pride in offering Filipino parents the additional option of storing their child's cord tissue to help them further safeguard their family's future."